Man Group
CTSO icon

Man Group’s Cytosorbents Corp CTSO Stock Holding History

Man Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,334
Closed -$83K – 1972
2018
Q4 		$83K Buy
+10,334
New +$103K ﹤0.01% 1858
2018
Q2 		– Sell
-13,760
Closed -$97K – 2128
2018
Q1 		$97K Buy
+13,760
New +$104K ﹤0.01% 1963

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Man Group's CTSO Position: Q1 2019 in Review

Man Group sold out of Cytosorbents Corp (CTSO) in Q1 2019, closing a stake of 10,334 shares — an estimated $83K sold.

Man Group first reported a position in CTSO in Q1 2018 and held it in 2 quarters. The position peaked at $97K in Q1 2018. 77 funds tracked by Wall St. Rank hold CTSO as of Q1 2019.

  • Man Group reported no remaining Cytosorbents Corp position as of Q1 2019 after selling out during the quarter.
  • Man Group sold 10,334 Cytosorbents Corp shares in Q1 2019, an estimated $83K.
  • Man Group first reported a position in Cytosorbents Corp in Q1 2018 and held it in 2 quarters.
  • Man Group's Cytosorbents Corp position peaked at $97K in Q1 2018.
  • 77 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2019.

Based on Man Group's 13F filing for Q1 2019, filed 15 May 2019.